Tatva Chintan Pharma Chem IPO Details
IPO Date	July 16, 2021 to July 20, 2021
Listing Date	July 29, 2021
Face Value	₹10 per share
Issue Price Band	₹1073 to ₹1083 per share
Issue Price Final	₹1083 per share
Lot Size	13 Shares
Sale Type	Fresh Capital-cum-Offer for Sale
Total Issue Size	46,16,804 shares
(aggregating up to ₹500.00 Cr)
Fresh Issue	20,77,562 shares
(aggregating up to ₹225.00 Cr)
Offer for Sale	25,39,242 shares of ₹10
(aggregating up to ₹275.00 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Pre Issue	2,00,87,500 shares
Share Holding Post Issue	2,21,65,062 shares
Tatva Chintan Pharma IPO Reservation
Tatva Chintan Pharma IPO offers total 46,16,804 shares. Out of which 23,08,401 (50.00%) allocated to QIB, 9,23,361 (20.00%) allocated to QIB, 6,92,521 (15.00%) allocated to NII, 16,15,882 (35.00%) allocated to RII and 13,85,040 (30.00%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
QIB Shares Offered	23,08,401 (50.00%)	NA
NII (HNI) Shares Offered	6,92,521 (15.00%)	NA
Retail Shares Offered	16,15,882 (35.00%)	1,24,298
Total Shares Offered	46,16,804 (100.00%)	
Tatva Chintan Pharma Chem IPO Anchor Investors Details
Tatva Chintan Pharma Chem IPO raises ₹150.00 crore from anchor investors. Tatva Chintan Pharma Chem IPO Anchor bid date is July 15, 2021. Tatva Chintan Pharma Chem IPO Anchor Investors list

Bid Date	July 15, 2021
Shares Offered	13,85,040
Anchor Portion Size (In Cr.)	150.00
Anchor lock-in period end date for 50% shares (30 Days)	August 25, 2021
Anchor lock-in period end date for remaining shares (90 Days)	October 24, 2021
Tatva Chintan Pharma Chem IPO Timeline (Tentative Schedule)
Tatva Chintan Pharma Chem IPO opens on July 16, 2021, and closes on July 20, 2021.

IPO Open Date	Fri, Jul 16, 2021
IPO Close Date	Tue, Jul 20, 2021
Tentative Allotment	Mon, Jul 26, 2021
Initiation of Refunds	Tue, Jul 27, 2021
Credit of Shares to Demat	Wed, Jul 28, 2021
Tentative Listing Date	Thu, Jul 29, 2021
Cut-off time for UPI mandate confirmation	5 PM on Tue, Jul 20, 2021
Tatva Chintan Pharma Chem IPO Lot Size
Investors can bid for a minimum of 13 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	13	₹14,079
Retail (Max)	14	182	₹1,97,106
S-HNI (Min)	15	195	₹2,11,185
S-HNI (Max)	71	923	₹9,99,609
B-HNI (Min)	72	936	₹10,13,688
Tatva Chintan Pharma Chem IPO Promoter Holding
Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.
Promoter Holding Pre Issue	100%
Promoter Holding Post Issue	79.17%
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

About Tatva Chintan Pharma Chem Ltd.
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.

The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.

Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.

Competitive strengths

Leading manufacturer of structure directing agents and phase transfer catalyst.
Diversified product portfolio.
Global market presence with customer base across industries.
Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
Experienced promoters and managers team.
Strong financial performance track record.
Company Financials
Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	3,148.03	2,489.38	1,875.08
Total Revenue	3,062.92	2,646.22	2,068.01
Profit After Tax	522.62	377.89	205.43
Objects of the Issue (Tatva Chintan Pharma Chem IPO Objectives)
The Company Tatva Chintan Pharma Chem IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

S.No.	Objects of the Issue	Expected Amount (₹ in crores)
1	Funding capital expenditure requirements for expansion of our Dahej Manufacturing Facility	147.10
2	Funding capital expenditure requirements for upgradation at our R&D facility in Vadodara; and	23.97
3	General corporate purposes	36.21
Tatva Chintan Pharma Chem IPO Review
[Dilip Davda]  The company is in a fast forward mode and the issue is reasonably priced. The green chemical industry is fancied by investors across the board. Investment may be considered for short to long term rewards. Read detail review...

Tatva Chintan Pharma IPO Subscription Status (Bidding Detail)
The Tatva Chintan Pharma IPO is subscribed 180.36 times on July 20, 2021 5:01:00 PM (Day 3). The public issue subscribed 35.35 times in the retail category, 185.23 times in the QIB category, and 512.22 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (times)	Shares Offered	Shares bid for
QIB	185.23	9,31,966	17,26,28,313
NII	512.22	6,98,975	35,80,28,073
Retail	35.35	16,30,941	5,76,52,010
Total	180.36	32,61,882	58,83,08,396
Tatva Chintan Pharma Chem IPO Prospectus
  ›  Tatva Chintan Pharma Chem IPO DRHP
  ›  Tatva Chintan Pharma Chem IPO RHP
  ›  Anchor Investors in Tatva Chintan Pharma Chem IPO
  ›  Tatva Chintan Pharma Chem IPO Final Prospectus
Tatva Chintan Pharma Chem IPO Listing Details
Listing Date	July 29, 2021
BSE Script Code	543321
NSE Symbol	TATVA
ISIN	INE0GK401011
Final Issue Price	₹1083 per share
BSE Listing Group	B (Rolling)
Pre-Open Session - NSEPre-Open Session - BSE

Listing Day Trading Information
Price Details	NSE SME	NSE SME
Final Issue Price	₹1,083.00	₹1,083.00
Open	₹2,111.80	₹2,111.85
Low	₹2,111.80	₹2,111.85
High	₹2,486.30	₹2,534.20
Last Trade	₹2,310.25	₹2,312.20